The Resource Biosimilars : Regulatory, Clinical, and Biopharmaceutical Development, edited by Hiten J. Gutka, Harry Yang, Shefali Kakar, (electronic resource)

Biosimilars : Regulatory, Clinical, and Biopharmaceutical Development, edited by Hiten J. Gutka, Harry Yang, Shefali Kakar, (electronic resource)

Label
Biosimilars : Regulatory, Clinical, and Biopharmaceutical Development
Title
Biosimilars
Title remainder
Regulatory, Clinical, and Biopharmaceutical Development
Statement of responsibility
edited by Hiten J. Gutka, Harry Yang, Shefali Kakar
Contributor
Editor
Editor
Provider
Subject
Language
eng
Summary
This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars. The development path of a biosimilar is just as unique as a development path of a new drug, tailored by the mechanism of action, the quality of the molecule, published information on the reference product, the current competitive environment, the target market and regulatory guidance, and most importantly, the emerging totality of evidence for the proposed biosimilar during development. For the ease of readers, the book comprises of six sections as follows: Section I: Business, Health Economics and Intellectual Property Landscape for Biosimilars Section II: Regulatory Aspects of Development and Approval for Biosimilars Section III: Biopharmaceutical Development and Manufacturing of Biosimilars Section IV: Analytical Similarity Considerations for Biosimilars Section V: Clinical aspects of Biosimilar Development Section VI: Biosimilars- Global Development and Clinical Experience Chapters have been written by one or more experts from academia, industry or regulatory agencies who have been involved with one or more aspects of biosimilar product development. The authors and editors have an expertise in commercialization and pricing of biosimilars, intellectual property considerations for biosimilars, chemistry manufacturing controls (CMC) and analytical development for biosimilars, regulatory and clinical aspects of biosimilar development. Besides the industry practitioners, the book includes several contributions from regulators across the globe
Member of
http://bibfra.me/vocab/relation/httpidlocgovvocabularyrelatorsedt
  • YGAc2XQyxXk
  • 8rqZslvwvNs
  • iAbT8CoFnaU
Image bit depth
0
LC call number
  • RS380
  • RS190-210
Literary form
non fiction
http://library.link/vocab/relatedWorkOrContributorName
  • Gutka, Hiten J.
  • Yang, Harry.
  • Kakar, Shefali.
  • SpringerLink
Series statement
AAPS Advances in the Pharmaceutical Sciences Series,
Series volume
34
http://library.link/vocab/subjectName
  • Pharmaceutical technology
  • Pharmacy
  • Pharmaceutical Sciences/Technology
  • Pharmacy
Label
Biosimilars : Regulatory, Clinical, and Biopharmaceutical Development, edited by Hiten J. Gutka, Harry Yang, Shefali Kakar, (electronic resource)
Instantiates
Publication
Antecedent source
mixed
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
not applicable
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
Section I: Biosimilars, Regulatory landscape, health economics and Intellectual Property landscape -- Biosimilars 101 – An Introduction to Biosimilars -- Innovation, Patents and Biologics: The Road to Biosimilar Competition -- Factors influencing investment, business decisions and marketing of biosimilars -- The Changing US Reimbursement Landscape and Biosimilars -- Litigation-Related Issues Under The Biologics Price Competition and Innovation Act -- Section II: Target Product Profile, QbD, CMC, Biosimilar manufacture platform technologies -- Design and implementation of successful regulatory strategies in biosimilar development -- Health Canada’s perspective on the clinical development of biosimilars and related scientific and regulatory challenges -- EU Perspective on Biosimilars -- Section III: Pharmaceutical development of Biosimilars; analytical comparability; higher order structure -- QbD in biopharmaceutical manufacturing and biosimilar development -- Drug Product Development and Manufacturing considerations for biosimilars -- Section IV: Biosimilars- clinical and non-clinical development; immunogenicity; Extrapolation and Interchangeability -- Principles of Analytical Biosimilarity Assessment -- Application of an Adaptive Analytical Characterization Strategy to Support Development and Approval of Biosimilars -- Higher Order Structure methods for similarity assessment -- Protein Conformational Array for Biologics Higher Order Structure Similarity Analysis -- Protein particulates and biosimilar development: analytical tools and therapeutic implications -- Biological activity assays for antibody therapeutics -- Statistical Considerations for Demonstration of Analytical Similarity -- Section V: Biosimilars- Global development and clinical experience -- Comparative clinical studies for biosimilar development -- Immunogenicity assessment of biosimilars: A multidisciplinary perspective -- Interchangeability of biosimilar therapeutics -- Extrapolation of Biosimilars -- Totality of evidence and the role of clinical studies in establishing biosimilarity -- Section VI: Biosimilars- Global Development and Clinical Experience -- Pharmacovigilance of Biosimilars – Global experience and perspective -- Development and Commercialization of Biosimilars in India – Current Regulatory and Clinical Experience.-Immunogenicty and adverse reactions to biocopy erythropoietins: The quality issues
Dimensions
unknown
Extent
XXIII, 709 p. 118 illus., 93 illus. in color.
File format
multiple file formats
Form of item
electronic
Isbn
9783319996806
Level of compression
uncompressed
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other control number
10.1007/978-3-319-99680-6
Other physical details
online resource.
Quality assurance targets
absent
Reformatting quality
access
Specific material designation
remote
System control number
(DE-He213)978-3-319-99680-6
Label
Biosimilars : Regulatory, Clinical, and Biopharmaceutical Development, edited by Hiten J. Gutka, Harry Yang, Shefali Kakar, (electronic resource)
Publication
Antecedent source
mixed
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
not applicable
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
Section I: Biosimilars, Regulatory landscape, health economics and Intellectual Property landscape -- Biosimilars 101 – An Introduction to Biosimilars -- Innovation, Patents and Biologics: The Road to Biosimilar Competition -- Factors influencing investment, business decisions and marketing of biosimilars -- The Changing US Reimbursement Landscape and Biosimilars -- Litigation-Related Issues Under The Biologics Price Competition and Innovation Act -- Section II: Target Product Profile, QbD, CMC, Biosimilar manufacture platform technologies -- Design and implementation of successful regulatory strategies in biosimilar development -- Health Canada’s perspective on the clinical development of biosimilars and related scientific and regulatory challenges -- EU Perspective on Biosimilars -- Section III: Pharmaceutical development of Biosimilars; analytical comparability; higher order structure -- QbD in biopharmaceutical manufacturing and biosimilar development -- Drug Product Development and Manufacturing considerations for biosimilars -- Section IV: Biosimilars- clinical and non-clinical development; immunogenicity; Extrapolation and Interchangeability -- Principles of Analytical Biosimilarity Assessment -- Application of an Adaptive Analytical Characterization Strategy to Support Development and Approval of Biosimilars -- Higher Order Structure methods for similarity assessment -- Protein Conformational Array for Biologics Higher Order Structure Similarity Analysis -- Protein particulates and biosimilar development: analytical tools and therapeutic implications -- Biological activity assays for antibody therapeutics -- Statistical Considerations for Demonstration of Analytical Similarity -- Section V: Biosimilars- Global development and clinical experience -- Comparative clinical studies for biosimilar development -- Immunogenicity assessment of biosimilars: A multidisciplinary perspective -- Interchangeability of biosimilar therapeutics -- Extrapolation of Biosimilars -- Totality of evidence and the role of clinical studies in establishing biosimilarity -- Section VI: Biosimilars- Global Development and Clinical Experience -- Pharmacovigilance of Biosimilars – Global experience and perspective -- Development and Commercialization of Biosimilars in India – Current Regulatory and Clinical Experience.-Immunogenicty and adverse reactions to biocopy erythropoietins: The quality issues
Dimensions
unknown
Extent
XXIII, 709 p. 118 illus., 93 illus. in color.
File format
multiple file formats
Form of item
electronic
Isbn
9783319996806
Level of compression
uncompressed
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other control number
10.1007/978-3-319-99680-6
Other physical details
online resource.
Quality assurance targets
absent
Reformatting quality
access
Specific material designation
remote
System control number
(DE-He213)978-3-319-99680-6

Library Locations

  • African Studies LibraryBorrow it
    771 Commonwealth Avenue, 6th Floor, Boston, MA, 02215, US
    42.350723 -71.108227
  • Alumni Medical LibraryBorrow it
    72 East Concord Street, Boston, MA, 02118, US
    42.336388 -71.072393
  • Astronomy LibraryBorrow it
    725 Commonwealth Avenue, 6th Floor, Boston, MA, 02445, US
    42.350259 -71.105717
  • Fineman and Pappas Law LibrariesBorrow it
    765 Commonwealth Avenue, Boston, MA, 02215, US
    42.350979 -71.107023
  • Frederick S. Pardee Management LibraryBorrow it
    595 Commonwealth Avenue, Boston, MA, 02215, US
    42.349626 -71.099547
  • Howard Gotlieb Archival Research CenterBorrow it
    771 Commonwealth Avenue, 5th Floor, Boston, MA, 02215, US
    42.350723 -71.108227
  • Mugar Memorial LibraryBorrow it
    771 Commonwealth Avenue, Boston, MA, 02215, US
    42.350723 -71.108227
  • Music LibraryBorrow it
    771 Commonwealth Avenue, 2nd Floor, Boston, MA, 02215, US
    42.350723 -71.108227
  • Pikering Educational Resources LibraryBorrow it
    2 Silber Way, Boston, MA, 02215, US
    42.349804 -71.101425
  • School of Theology LibraryBorrow it
    745 Commonwealth Avenue, 2nd Floor, Boston, MA, 02215, US
    42.350494 -71.107235
  • Science & Engineering LibraryBorrow it
    38 Cummington Mall, Boston, MA, 02215, US
    42.348472 -71.102257
  • Stone Science LibraryBorrow it
    675 Commonwealth Avenue, Boston, MA, 02445, US
    42.350103 -71.103784
Processing Feedback ...